Survey on preferences for screening tools in gastro-esophageal cancer
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
This study is asking people about their preferences for different tests used to find and check gastro-esophageal cancer to help improve future screening methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2200 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT06346080 on ClinicalTrials.gov |
What this trial studies
This survey aims to explore patient and public preferences for different diagnostic tools used in detecting and assessing gastro-esophageal cancer. Participants will complete a 20-25 minute survey that includes questions about their socio-economic status and preferences regarding various diagnostic modalities. The study will also investigate geographical differences in preferences and identify which features of diagnostic tests influence decision-making. By analyzing these preferences, the study seeks to inform future diagnostic practices in gastro-esophageal cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 to 75 who have access to a computer or smartphone and can understand the survey languages.
Not a fit: Patients under 18 or over 75 years old, as well as incarcerated individuals, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient-centered approaches in the screening and diagnosis of gastro-esophageal cancer.
How similar studies have performed: While there have been studies on patient preferences in cancer diagnostics, this specific approach using a discrete choice experiment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance) 2. Access to computer or smartphone 3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese) Exclusion Criteria: 1. Individuals less than 18yo and more than 75yo 2. Incarcerated individuals
Where this trial is running
Leuven
- University Hospitals Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Principal investigator: Stijn Vanstraelen, MD — UZ Leuven
- Study coordinator: Stijn Vanstraelen, MD
- Email: stijn.vanstraelen@kuleuven.be
- Phone: 16346822
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.